Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...
The Special Intensive Revision (SIR) is a flagship program of the Election Commission of India (ECI) to verify, update, and include electoral rolls across the country. It is a special verification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback